English
Home > Products > CAS:17183-98-1

China CAS:17183-98-1 Manufacturer

Our pros are reduce price ranges,dynamic gross sales staff,specialized QC,potent factories,premium quality services for CAS:17183-98-1, We welcome all with the consumers and pals to call us for mutual positive aspects. Hope to do additional company along with you.
CAS:17183-98-1, We are eager to cooperate with foreign companies which care much on the real quality, stable supply, strong capability and good service. We can offer the most competitive price with high quality,because we are much MORE PROFESSIONAL. You are welcomed to visit our company at any time.

Related Products

Hot Products

  • Budesonide

    Budesonide

    Budesonide has USP, EP specifications. CEP, GMP and FDA approved.

    CAS:51333-22-3

  • Levonorgestrel

    Levonorgestrel

    Levonorgestrel has speficications of CP/EP/USP. DMF,GMP and CEP available.

    CAS:797-63-7

  • Nintedanib Esylate

    Nintedanib Esylate

    Nintedanib Esylate has in-house specification. DMF available.

    CAS:656247-18-6

  • Triacetyl-ganciclovir

    Triacetyl-ganciclovir

    Triacetyl-ganciclovir is a Ganciclovir derivative.

    CAS:86357-14-4

  • Compound Mifepristone Tablets

    Compound Mifepristone Tablets

    Compound Mifepristone Tablets Specifications：Mifepristone 30mg Anorethidrane 5mg*2
    Indications：Abortion
  • Luliconazole

    Luliconazole

    Luliconazole has In-house specification, DMF approved.

    CAS:187164-19-8

  • Related Blog
  • Reviews

  • 2021 API Exhibition Guangzhou

    May 2021
    API China is a well-established comprehensive pharmaceuticals and chemicals show in Chinese pharmaceutical industry. With more than 40 years’ experience in China, it has been a well-known celebration for all parties involved in Chinese Pharmaceutical market.

  • 2022 API Exhibition Qingdao

    August 2022
    Founded by China National Medical Control Bureau (the predecessor of NPMA) in 1968.
    Gathering 97% of Top 100 Chinese pharmaceutical enterprises.
    99% manufactures meets the requirements of GMP.
    Supported by numerous powerful associations in China: CCFDIE, CPIA, CBPIA, CATCM, CNMA, CNPPA, etc.

  • 2022 CPhI Exhibition Shanghai

    CPhI is the undisputed leader in the pharmaceutical industry. CPhI China offers a key access point to the second largest pharma market in the world. The exhibition features over 3,000 companies and incorporates various API showcases like bioLIVE, iCSE, NEX and FDF, creating a comprehensive platform that connects the entire pharmaceutical industry chain in the Asian-Pacific region.

  • Visit us at CPHI Frankfurt - Booth 12.1C3!

    CPHI Frankfurt 2025 will be held at Messe Frankfurt from October 28 to 30, our booth number is 12.1C3.

  • How Can Intermediates Category Solutions Streamline Your Production Process

    As someone who has spent over two decades navigating the complexities of industrial production, I've seen firsthand how bottlenecks in the middle stages can derail entire operations. That’s why I was particularly impressed when I began working with solutions from the Intermediates Category. For any production manager, finding tools that seamlessly integrate and accelerate the core of your workflow is the ultimate goal. This is where the strategic approach from Humanwell truly shines, offering a refined path to efficiency that many of us have been searching for.

  • CPHI China 2026 | June 16-18, Looking forward to meeting you

    CPHI China will be staged at Shanghai New International Expo Center on June 16-18, 2026 together with ICSE & PMEC China,our booth number is W1G20.

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept